Early research (Phase 1)Looking for participantsNCT07249840What this trial is testingRopeginterferon for High Risk JAK2 Clonal HematopoiesisWho this might be right forJAK2 Mutation Brigham and Women's Hospital 12
Early research (Phase 1)Study completedNCT00602693What this trial is testingT-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Masonic Cancer Center, University of Minnesota 41
Early research (Phase 1)Study completedNCT01795716What this trial is testingBioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia BodyWho this might be right forChronic Myeloid Leukemia Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT02125318What this trial is testingAnagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow DisordersWho this might be right forThrombocytosisMyeloproliferative Neoplasms Galena Biopharma, Inc. 18
Testing effectiveness (Phase 2)UnknownNCT01240525What this trial is testingDonor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological CancersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more University College, London 114
Not applicableEnded earlyNCT00608517What this trial is testingTreatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Vanderbilt-Ingram Cancer Center 6
Large-scale testing (Phase 3)WithdrawnNCT00349518What this trial is testingStudy of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLWho this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT01613976What this trial is testingA Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) PatientsWho this might be right forMyelodysplastic Syndromes (MDS)Chronic Myelomonocytic Leukemia (CMML)Acute Myeloid Leukemia (AML) Novartis Pharmaceuticals 10
Not applicableStudy completedNCT01244750What this trial is testingStudying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world SettingWho this might be right forChronic Myeloid Leukemia Bristol-Myers Squibb 1,494
Testing effectiveness (Phase 2)UnknownNCT01221376What this trial is testingPhase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)Who this might be right forChronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+) Renato Melaragno 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07649369What this trial is testingA Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural EffusionWho this might be right forMalignant Pleural Effusions (Mpe) Shanghai Jeyou Pharmaceutical Co., Ltd. 120
Post-approval studies (Phase 4)Study completedNCT07105319What this trial is testingRopeginterferon for Treatment Free RemissionWho this might be right forCML (Chronic Myelogenous Leukemia) Dong-Wook Kim 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT00392353What this trial is testingVorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid LeukemiaWho this might be right forAcute Erythroid LeukemiaAcute Megakaryoblastic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+6 more National Cancer Institute (NCI) 135
Large-scale testing (Phase 3)Study completedNCT00043381What this trial is testingDecitabine Versus Supportive Care in Adults With Advanced-stage MDSWho this might be right forMyelodysplastic Syndrome Astex Pharmaceuticals, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3
Early research (Phase 1)Looking for participantsNCT04024761What this trial is testingTrial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell TransplantationWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more Dana-Farber Cancer Institute 50
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Not applicableStudy completedNCT00296023What this trial is testingDonor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of California, San Francisco 25
Testing effectiveness (Phase 2)Study completedNCT00041990What this trial is testingPhase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)Who this might be right forChronic Myelogenous Leukemia Astex Pharmaceuticals, Inc. 40